Fabian Gerlinghaus, CEO  Oct. 13 | 10:30am | Oxford Biomedica Ballroo San Francisco, CA  (Private)  In-Person Presentation  Cellares is creating the future of cell therapy manufacturing and accelerating access to life-saving cell therapies. The company is developing the Cell Shuttle, a scalable solution to make cell therapies more affordable and widely...

Robert Ang, President and CEO Oct. 12 | 5:15pm | UBC Ballroom   Cambridge, MA  (NASDAQ: VOR)  In-person Presentation  Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant.  www.vorbio.com ...

Barbara Sanders, Ph.D., Vice President, Vector Development Oct. 13 | 11:45am | Oxford Biomedica Ballroom  Amsterdam, Netherlands   (Private)  In-person Presentation  VectorY combines the therapeutic potential of antibodies and gene therapy to develop long-lasting therapeutic solutions for large disease areas of high unmet medical need. Founded in August 2020, and based...

Stephane Boissel, President and CEO Oct. 12 | 2:15pm | Oxford Biomedica Ballroom   Paris, France  (Private)  In-person Presentation  SparingVision is a genomic medicines company with a mission to translate pioneering science into vision saving treatments. Leveraging its unparalleled understanding of retinal diseases, SparingVision has built the world’s most compelling portfolio of...

Rogerio Vivaldi, M.D., President and CEO Oct. 11 | 1:45pm | Oxford Biomedica Ballroom   Cambridge, MA (NASDAQ: SGTX)  In-person Presentation  Sigilon Therapeutics seeks to develop functional cures for patients with a broad range of chronic diseases by harnessing the power of the human cell through its Shielded Living Therapeutics™ platform. Sigilon’s product...

Matthew Klein, M.D., Chief Operating Officer Oct. 11 | 12:00pm | UBC Ballroom   South Plainfield, NJ  (NASDAQ: PTCT)  In-person Presentation  PTC Therapeutics is a science-driven, global biopharmaceutical company focused on the discovery, development, and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to innovate to...

Brian Lee, Ph.D., President and CEO Oct. 12 | 3:45pm | Oxford Biomedica Ballroom   Camarillo, CA  (Private)  In-person Presentation  PBS Biotech offers innovative single-use bioreactors as well as contract process development services for the global cell therapy market. Our unique Vertical-Wheel® bioreactor provides ideal fluid mixing conditions for sensitive human cells...

Dr. Gregory Block, Senior Vice President, Corporate Development  Oct. 12 | 11:15am | Oxford Biomedica Ballroom  Vancouver, Canada  (Private)  In-person Presentation  Notch Therapeutics is a biotechnology company developing renewable, induced pluripotent stem cell (iPSC)-derived immunotherapies, with an initial focus on cancer where cell therapies offer transformational benefits over existing standards of...

Yan Zhang, Ph.D., CEO Oct. 11 | 1:30pm | Oxford Biomedica Ballroom   San Francisco, CA  (Private)  In-person Presentation  Mission Bio is a life sciences company that accelerates discoveries and cures for a wide range of diseases by equipping researchers with the tools they need to better measure, characterize, and predict our...

Cenk Sumen, Chief Technology Officer  Oct. 12 | 4:45pm | Oxford Biomedica Ballroom  Gaithersburg, MD  (NASDAQ: MXCT)  In-person Presentation  MaxCyte® is a leading provider of cell-engineering platform technologies and is responsible for helping to bring next‐generation cell-based therapies to life. The company's technology is employed by leading drug developers worldwide,...

By using this website you agree to accept our Privacy Policy and Terms & Conditions